Refers to a medication or treatment that is administered to prevent future relapsesWhen you present to your doctor or hospital with new or worsening central nervous system symptoms. Generally, if your symptoms gradually worsen over 24-48 hours, there is heightened concern of a relapse. (Also referred to as a flare by the myelin oligodendrocyte glycoproten antibody disease (MOGAD) community). (Also referred to as Preventative or Preventive Treatment).
Related Posts
Gabriela’s Story: A Story of Faith, Strength, and Resilience
My name is Gabriela Nunez, though most people know me as Gabby. I am 26 years old, a wife, and a proud mother of three
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease meetings focused onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. research priorities, clinical trials, therapeutic